Adult cells can acquire high plasticity,

without changing the genetic code.

Your body already solved aging-related repair.

We unlocked it to rebuild what chronic disease takes away.

APstem's mission is to restore the body's original regenerative potential by reawakening a dormant regenerative blueprint already in adult cells.

Unlike iPSCs or ESCs that require artificial reprogramming or ethical compromise, APstem:

Discovers: A dormant regenerative code in adult human blood.
Activates: This cell ex vivo—without changing the genetic code.
Transforms: High-plasticity cells that can take on the identity of the tissue around them.
Restores: The regenerative intelligence that is innate but silenced after early development.

This is a new class of regenerative medicine: high plasticity, without reprogramming, designed for off-the-shelf use." A promise the stem cell industry failed to deliver without reprogramming, until we came on the scene.

TECHNOLOGY

A New Kind Of Stem Cell.

APstem is developing a first-in-class regenerative cell therapy based on a patented, proprietary platform called Guide-Integrated Adult Stem Cells (giaSCs). We make them from two human cell types: blood-derived guide cells and umbilical-cord stromal cells.

No added genes. No gene editing. Just cells talking to cells.

These novel stem cells are designed to address the root cause of serious chronic diseases, starting with type 1 diabetes.

Why APstem’s giaSCs Are Different

🧬 Dual Role: Designed to support tissue repair and help rebalance the immune system — the two problems at the heart of type 1 diabetes.
✅ Excellent Safety Profile: No tumorigenicity observed in long-term animal models; No added genes. Designed for use without encapsulation or immunosuppression.
💉 Allogeneic, Off-the-Shelf: Made from healthy donor cells and designed for more than one recipient, ready when patients need it.
🔄 Type 1 diabetes first. Healthy longevity next.

One platform: regenerative repair with immune balance, designed to be used off the shelf.